Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04270279

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04270279
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04270279. Randomized; quadruple masking; primary purpose treatment. Start 2020-12 (anticipated); primary completion 2021-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
Condition
Coronary Heart Disease
Condition
Stable Angina
Intervention (Drug)
Xueshuanxinmaining tablet
Intervention (Drug)
Xueshuanxinmaining placebo
Intervention (Drug)
Nitroglycerin tablets
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct04270279
Content hash
6417f33f875277dc25b7ae94a46661c0a49eb15f0ed36aa776d7ffa059cce81c